GlycoMimetics

+$0.01 (+0.49%) Today
+$0.05 (+2.43%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO
Rachel K. King
Employees
54
Headquarters
Rockville, Maryland
Founded
2003

GLYC Key Statistics

Market Cap
140.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
347.33K
High Today
$2.09
Low Today
$2.03
Open Price
$2.04
Volume
175.03K
52 Week High
$4.48
52 Week Low
$1.96

GLYC Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure